查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1371939

全球 HIV 診斷市場，到 2030 年的預測：按產品、測試類型、最終用戶和地區進行的全球分析

HIV Diagnosis Market Forecasts to 2030 - Global Analysis By Product, Test Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球 HIV 診斷市場規模將達到 10.596 億美元，預計到 2030 年將達到 17.579 億美元，預測期內年複合成長率為 7.4%。

HIV診斷是指辨識個體體內是否存在人類免疫力缺乏病毒（HIV）的過程。這通常是透過各種實驗室測試來完成的，這些測試可檢測血液、唾液和其他體液中病毒的特異性標記，例如 HIV 抗體和病毒遺傳物質。準確的診斷對於確定個人的愛滋病毒狀況至關重要，對於開始治療、控制疾病和預防其傳播也至關重要。

根據世界衛生組織（WHO）統計，2016年全球約有3,600萬人被診斷出感染愛滋病毒，其中210萬人是新感染者。

愛滋病毒診斷的需求不斷成長

人類免疫力缺乏病毒（HIV）會導致後天免疫力缺乏症候群，可以透過愛滋病毒診斷來檢測，從而增加了對這些服務的需求。此外，由於可以透過檢測血清、唾液和尿液來診斷 HIV，並有助於檢測抗體、抗原和 RNA，因此 HIV 診斷流程的銷售額預計將增加。此外，隨著人們對愛滋病毒、檢測保密性和適當諮詢的了解越來越多，對愛滋病毒診斷的需求也在增加。因此，由於這些要素，愛滋病毒診斷市場預計將迅速擴大。

成本高

HIV 診斷測試可能很昂貴，具體取決於情況和測試類型，特別是如果它們先進且精確的話。此外，與檢測相關的成本可能是一個障礙，特別是對於資源匱乏地區或無法獲得足夠醫療保健的人來說。其結果是，市場擴張將受到明顯抑制。

政府系統和計劃

世界各國政府正在加緊配合措施，透過實施優先考慮預防、檢測和治療的綜合計畫來對抗愛滋病毒/愛滋病流行。此外，這些計劃旨在提高常規愛滋病毒檢測的普及，特別是在高風險族群中，並讓人們獲得最先進的診斷工具。此外，各國政府也鼓勵製藥公司、非政府組織(NGO) 和醫療保健組織之間進行合作，以提高愛滋病毒診斷設備的可用性和成本，從而減輕全球愛滋病毒負擔。透過共同努力實現這一目標，我們鼓勵市場擴張。

缺乏知識和假陽性結果

許多人，特別是生活在高風險地區的人，不知道早期診斷的價值，對愛滋病毒檢測的了解也有限。檢測率低和診斷延遲可能是由於缺乏教育和意識，阻礙了適當的管理和預防措施。此外，假陽性會導致過度的擔憂和壓力，而假陰性會延遲診斷並增加病毒感染的風險。因此，這些要素正逐漸阻礙市場規模。

COVID-19 的影響

冠狀病毒 (COVID-19)大流行導致的全球封鎖正在影響各行業公司的財務健康狀況。此外，由於政府封鎖、旅行限制和其他 COVID-19 安全措施，全球供應鏈和製造業務也受到了影響。因此，愛滋病毒診斷檢測的需求預計在流行期間會減少。

預計設備部分在預測期內將是最大的

由於可以利用專門的醫療工具和技術來檢測和追蹤愛滋病毒感染，因此設備部分估計佔最大佔有率。此外，這些技術使醫療保健專業人員能夠準確地識別患者樣本中的愛滋病毒抗體和病毒遺傳物質。這些設備的範例包括 PCR 機、ELISA 分析儀和快速檢測儀等診斷工具。此外，這些尖端工具對於早期檢測、疾病監測和研究至關重要，從而實現快速、準確的愛滋病毒檢測。我們也幫助醫療保健專業人員、實驗室和診所提供有效的診斷解決方案，並促進繼續配合措施遏制愛滋病毒的傳播。因此，這些要素正在顯著推動市場規模。

CD4 測試領域預計在預測期內年複合成長率最高

預計 CD4 測試領域在預測期內年複合成長率最高。 CD4 檢測對於控制 HIV/愛滋病至關重要，因為它可以指示疾病的病程並檢測患者免疫系統的健康狀況。此外，這些測試可以幫助醫療專業人員決定治療計劃並評估抗逆轉錄病毒藥物的有效性。此外，準確、快速的 CD4 檢測對於指導患者護理和控制疾病至關重要。因此，透過在愛滋病毒診斷市場中發揮重要作用，我們將為改善愛滋病毒感染者的治療結果和整體生活品質做出貢獻。

比最大的地區

由於印度、中國和日本等國家宣傳活動的加強和愛滋病毒診斷數量的增加，亞太地區在預測期內佔據了最大的市場佔有率。此外，社會經濟和人口要素的變化正在增加這些國家的愛滋病毒診斷數量。此外，增加對醫療機構和意識計劃的投資也支持亞太地區的市場擴張。

複合年複合成長率最高的地區

由於在促進早期檢測、制定國家檢測政策和增加愛滋病毒檢測服務的可及性方面取得了重大進展，預計歐洲在預測期內的年複合成長率最高。此外，該地區的目標是減少與愛滋病毒相關的恥辱和歧視，從而鼓勵人們接受檢測。此外，政府、醫療機構和非政府組織之間的合作有助於提高檢測率並加快診斷速度，從而顯著促進歐洲地區的市場擴張。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究來源
    • 主要研究來源
    • 二次研究來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球愛滋病毒診斷市場：依產品

  • 軟體和服務
  • 裝置
  • 消耗品
    • 測定及試劑盒/試劑
    • 其他消耗品

第6章 全球HIV 診斷市場：依測試類型

  • 抗體測試
    • HIV-1 篩檢測試
      • 酵素連結免疫吸附試驗
      • 首頁訪問乾血斑
      • 快速測試
    • HIV-1抗體確認試驗
      • 蛋白質印跡試驗
      • 線性免疫分析
      • 間接螢光分析 (IFA)
      • 放射免疫沉澱測定
    • HIV-2 和 O 組診斷測試
  • 病毒量測試
  • 嬰兒早期診斷測試
  • CD4測試
  • 病毒鑑定測試

第7章 全球HIV 診斷市場：依最終用戶分類

  • 醫院/診所
  • 診斷實驗室
  • 居家醫療環境
  • 其他最終用戶

第8章 全球愛滋病毒診斷市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abbott Laboratories
  • Roche Diagnostics
  • Merck KGaA
  • Siemens Healthineers
  • Thermo-Fisher Scientific Inc.
  • Beckman Coulter, Inc.
  • Hologic Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories
  • Alere Inc.
  • OraSure Technologies, Inc.
  • Zyomyx Incorporation
  • Chembio Diagnostic Systems, Inc.
  • Janssen Pharmaceutica NV
  • Bristol-Myers Squibb
Product Code: SMRC23996

According to Stratistics MRC, the Global HIV Diagnosis Market is accounted for $1059.6 million in 2023 and is expected to reach $1757.9 million by 2030 growing at a CAGR of 7.4% during the forecast period. HIV diagnosis refers to the process of identifying the presence of the human immunodeficiency virus (HIV) in an individual's body. It is typically accomplished through various laboratory tests that detect specific markers of the virus, such as HIV antibodies or viral genetic material in blood, saliva, or other bodily fluids. The accurate diagnosis is essential for determining an individual's HIV status, which is crucial for initiating treatment, managing the disease, and preventing its spread.

According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections.

Market Dynamics:

Driver:

Rising demand for HIV diagnosis

Since the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome, may be detected by HIV diagnostics, by which there is an increasing need for these services. Moreover, testing serum, saliva, or urine samples allows for the diagnosis of HIV and as these methods assist in detecting antibodies, antigens, and RNA, it is projected that sales of HIV diagnostic processes will rise. Additionally, as people become more knowledgeable about HIV, the confidentiality of the test, and appropriate counselling, the demand for HIV diagnostics is also rising. Hence, the HIV diagnostics market is anticipated to expand quickly as a result of these factors.

Restraint:

High expenses

HIV diagnostic tests can be expensive, particularly for more sophisticated and precise testing procedures, depending on the context and type of test. Additionally, costs associated with testing can be an obstacle, especially in environments with few resources or for people without access to adequate healthcare. Consequently, this considerably disrupts the market's expansion.

Opportunity:

Government schemes and programs

Worldwide, governments are stepping up their efforts to tackle the HIV/AIDS pandemic by putting in place comprehensive plans that prioritize prevention, testing, and treatment. Additionally, these programs seek to increase the prevalence of routine HIV testing, particularly among high-risk populations, and to open up access to cutting-edge diagnostic tools. Furthermore, governments also encourage collaborations among pharmaceutical firms, non-governmental organizations (NGOs), and healthcare organizations to increase the accessibility and cost of HIV diagnostic equipment, which in turn drives market expansion as they cooperate to mitigate the burden of HIV worldwide

Threat:

Lack of knowledge and false-positive results

A lot of people, especially those who live in high-risk areas, can be unaware of the value of early diagnosis and have limited knowledge about HIV testing. Low testing rates and delayed diagnoses might be caused by a lack of education and awareness actions, hindering adequate management and prevention measures. Furthermore, false-positive results can result in too much worry and stress, while false-negative results can delay diagnosis and increase the risk of virus transmission. Thus, these factors gradually hamper the size of the market.

COVID-19 Impact

The global lockdown caused by the corona virus (COVID-19) pandemic has had an effect on the financial health of companies in all industries. Additionally, global supply chains and manufacturing operations have been affected as a result of government-enforced lockdowns, mobility restrictions, and other COVID-19 safety measures. Therefore, during the epidemic, the need for HIV diagnostic tests is anticipated to decline.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is estimated to hold the largest share, due to utilizing specialized medical tools and technology, HIV infection is detected and tracked. Additionally, these technologies enable medical personnel to precisely identify HIV antibodies or viral genetic material in patient samples. Examples of these devices include diagnostic tools including PCR machines, ELISA analyzers, and quick test readers. Moreover, these cutting-edge tools are essential for early detection, disease monitoring, and research, enabling quick and accurate HIV testing. They also assist healthcare professionals, labs, and clinics in delivering efficient diagnostic solutions, which helps to further the continuing efforts to restrict the spread of HIV. Therefore, these factors significantly drive the market's size.

The CD4 Tests segment is expected to have the highest CAGR during the forecast period

The CD4 Tests segment is anticipated to have highest CAGR during the forecast period. CD4 tests are essential for controlling HIV/AIDS since they show the disease's course and measure the patient's immune system's health. Additionally, these tests assist medical professionals in deciding on a course of treatment and assessing the efficacy of antiretroviral medication. Moreover, for directing patient care and managing diseases, accurate and prompt CD4 testing is essential. Thus, it contributes to better treatment outcomes and overall quality of life for people with HIV by playing a vital role in the market for HIV diagnosis.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing awareness-raising campaigns in nations like India, China, and Japan have increased the number of HIV diagnoses. Moreover, because of shifting socioeconomic and demographic factors, there are more HIV diagnoses in these nations. Additionally, rising healthcare institution and awareness program investments are driving market expansion in the Asia Pacific region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to significant progress in boosting early detection, creating national testing policies, and increasing access to HIV testing services. Additionally, the area aims to reduce the stigma and discrimination related to HIV, which encourages people to be tested. Furthermore, governments, healthcare institutions, and NGOs working together have increased testing rates and accelerated diagnosis which thus significantly propels the market expansion in Europe region.

Key players in the market:

Some of the key players in the HIV Diagnosis Market include: Abbott Laboratories, Roche Diagnostics, Merck KGaA, Siemens Healthineers, Thermo-Fisher Scientific Inc., Beckman Coulter, Inc., Hologic Inc., Becton, Dickinson & Company , Bio-Rad Laboratories, Alere Inc., OraSure Technologies, Inc., Zyomyx Incorporation, Chembio Diagnostic Systems, Inc., Janssen Pharmaceutica NV and Bristol -Myers Squibb.

Key Developments:

In August 2023, Abbott Laboratories has collaborated with Redcliffe Labs to introduce Clinical Decision Support (CDS) also known as AlinIQ, powered by various proprietary technologies including Big Data Engines and Artificial Intelligence (AI). This development aims to revolutionise healthcare, offering solutions to enhance patient care and convenience.

In Jan 2022, Bristol-Myers Squibb and Century Therapeutics enter into a strategic collaboration to develop iPSC-derived Allogeneic Cell Therapies. The collaboration with Century Therapeutics is an important part of their investment strategy in next-generation cell therapies for hematologic and solid tumors.

Products Covered:

  • Software & Services
  • Instruments
  • Consumables

Test Types Covered:

  • Antibody Tests
  • Viral Load Tests
  • Tests for Early Infant Diagnosis
  • CD4 Tests
  • Tests for Viral Identification

End Users Covered:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global HIV Diagnosis Market, By Product

  • 5.1 Introduction
  • 5.2 Software & Services
  • 5.3 Instruments
  • 5.4 Consumables
    • 5.4.1 Assays and Kits & Reagents
    • 5.4.2 Other Consumables

6 Global HIV Diagnosis Market, By Test Type

  • 6.1 Introduction
  • 6.2 Antibody Tests
    • 6.2.1 HIV-1 Screening Tests
      • 6.2.1.1 Elisa
      • 6.2.1.2 Home Access Dried Blood Spots
      • 6.2.1.3 Rapid Tests
    • 6.2.2 HIV-1 Antibody Confirmatory Tests
      • 6.2.2.1 Western Blot Tests
      • 6.2.2.2 Line Immunoassays
      • 6.2.2.3 Indirect Immunofluorescence Assays (IFA)
      • 6.2.2.4 Radio-Immunoprecipitation Assays
    • 6.2.3 HIV-2 & Group O Diagnostic Tests
  • 6.3 Viral Load Tests
  • 6.4 Tests for Early Infant Diagnosis
  • 6.5 CD4 Tests
  • 6.6 Tests for Viral Identification

7 Global HIV Diagnosis Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals & Clinics
  • 7.3 Diagnostic Laboratories
  • 7.4 Home Settings
  • 7.5 Other End Users

8 Global HIV Diagnosis Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Roche Diagnostics
  • 10.3 Merck KGaA
  • 10.4 Siemens Healthineers
  • 10.5 Thermo-Fisher Scientific Inc.
  • 10.6 Beckman Coulter, Inc.
  • 10.7 Hologic Inc.
  • 10.8 Becton, Dickinson & Company
  • 10.9 Bio-Rad Laboratories
  • 10.10 Alere Inc.
  • 10.11 OraSure Technologies, Inc.
  • 10.12 Zyomyx Incorporation
  • 10.13 Chembio Diagnostic Systems, Inc.
  • 10.14 Janssen Pharmaceutica NV
  • 10.15 Bristol -Myers Squibb

List of Tables

  • Table 1 Global HIV Diagnosis Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 4 Global HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 6 Global HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 7 Global HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 8 Global HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 9 Global HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 10 Global HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 11 Global HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 12 Global HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 13 Global HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 14 Global HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 15 Global HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 16 Global HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 17 Global HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 18 Global HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 19 Global HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 20 Global HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 21 Global HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 22 North America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 23 North America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 24 North America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 25 North America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 26 North America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 27 North America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 28 North America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 29 North America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 30 North America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 31 North America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 32 North America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 33 North America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 34 North America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 35 North America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 36 North America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 37 North America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 38 North America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 North America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 40 North America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 41 North America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 42 North America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 43 Europe HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Europe HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 45 Europe HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 46 Europe HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 47 Europe HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 48 Europe HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 49 Europe HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 50 Europe HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 51 Europe HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 52 Europe HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 53 Europe HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 54 Europe HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 55 Europe HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 56 Europe HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 57 Europe HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 58 Europe HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 59 Europe HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 60 Europe HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 61 Europe HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 62 Europe HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 63 Europe HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 64 Asia Pacific HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 65 Asia Pacific HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 66 Asia Pacific HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 67 Asia Pacific HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 68 Asia Pacific HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 69 Asia Pacific HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 70 Asia Pacific HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 71 Asia Pacific HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 72 Asia Pacific HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 73 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 74 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 75 Asia Pacific HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 76 Asia Pacific HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 77 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 78 Asia Pacific HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 79 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 80 Asia Pacific HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 81 Asia Pacific HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 82 Asia Pacific HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 83 Asia Pacific HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 84 Asia Pacific HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 85 South America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 86 South America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 87 South America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 88 South America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 89 South America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 90 South America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 91 South America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 92 South America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 93 South America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 94 South America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 95 South America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 96 South America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 97 South America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 98 South America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 99 South America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 100 South America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 101 South America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 102 South America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 103 South America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 104 South America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 105 South America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 106 Middle East & Africa HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
  • Table 107 Middle East & Africa HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
  • Table 108 Middle East & Africa HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 109 Middle East & Africa HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 110 Middle East & Africa HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 111 Middle East & Africa HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
  • Table 112 Middle East & Africa HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
  • Table 113 Middle East & Africa HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 114 Middle East & Africa HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
  • Table 115 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
  • Table 116 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
  • Table 117 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
  • Table 118 Middle East & Africa HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
  • Table 119 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
  • Table 120 Middle East & Africa HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
  • Table 121 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
  • Table 122 Middle East & Africa HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
  • Table 123 Middle East & Africa HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 124 Middle East & Africa HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 125 Middle East & Africa HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
  • Table 126 Middle East & Africa HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)